EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer

Yanara A Bernal iD, Eduardo Durán iD, Isidora Solar, Eduardo A Sagredo iD, Ricardo Armisén iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yanara A Bernal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Genética y Genómica, Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana Universidad del Desarrollo…. Hauptthemen laut MEDLINE: RNA Editing, Adenosine Deaminase, Breast Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, FONDECYT REGULAR, PhD program in Science and Innovation in Medicine, Facultad de Medicina Clínica Alemana Universidad del Desarrollo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epitranscriptomics is a field that delves into post-transcriptional changes. Among these modifications, the conversion of adenosine to inosine, traduced as guanosine (A>I(G)), is one of the known RNA-editing mechanisms, catalyzed by ADARs. This type of RNA editing is the most common type of editing in mammals and contributes to biological diversity. Disruption in the A>I(G) RNA-editing balance has been linked to diseases, including several types of cancer. Drug resistance in patients with cancer represents a significant public health concern, contributing to increased mortality rates resulting from therapy non-responsiveness and disease progression, representing the greatest challenge for researchers in this field. The A>I(G) RNA editing is involved in several mechanisms over the immunotherapy and genotoxic drug response and drug resistance. This review investigates the relationship between ADAR1 and specific A>I(G) RNA-edited sites, focusing particularly on breast cancer, and the impact of these sites on DNA damage repair and the immune response over anti-cancer therapy. We address the underlying mechanisms, bioinformatics, and in vitro strategies for the identification and validation of A>I(G) RNA-edited sites. We gathered databases related to A>I(G) RNA editing and cancer and discussed the potential clinical and research implications of understanding A>I(G) RNA-editing patterns. Understanding the intricate role of ADAR1-mediated A>I(G) RNA editing in breast cancer holds significant promise for the development of personalized treatment approaches tailored to individual patients’ A>I(G) RNA-editing profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA EditingAdenosine DeaminaseBreast NeoplasmsRNA-Binding ProteinsHumansFemaleAdenosineDrug Resistance, NeoplasmInosineAnimalsGuanosineDNA Damage

Stichwörter der Autor:innen

A>I(G)ADAR1DNA damage repairRNA editingbreast cancerdrug resistancedrug responseimmune responsesplicing alteration

Substanzen

Adenosine DeaminaseADAR protein, humanRNA-Binding ProteinsAdenosineInosineGuanosine

Autor:innen und Institutionen

  • Centro de Genética y Genómica, Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7610658, Chile.
  • Subdepartamento de Genómica y Genética Molecular, Sección Genética Humana, Instituto de Salud Pública de Chile, Avenida Marathon 1000, Ñuñoa, Santiago 7780050, Chile.
  • Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Science for Life Laboratory, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-171 77 Stockholm, Sweden.

ORCID-Profile: Yanara A Bernal, Eduardo Durán, Eduardo A Sagredo, Ricardo Armisén

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • FONDECYT REGULAR
  • PhD program in Science and Innovation in Medicine, Facultad de Medicina Clínica Alemana Universidad del Desarrollo

Zitieren

APA

Bernal, Y. A., Durán, E., Solar, I., Sagredo, E. A., & Armisén, R. (2024). ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137424

Vancouver

Bernal YA, Durán E, Solar I, Sagredo EA, Armisén R. ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137424

BibTeX
@article{Bernal2024,
  author = {Bernal, Yanara A and Durán, Eduardo and Solar, Isidora and Sagredo, Eduardo A and Armisén, Ricardo},
  title = {ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137424}
}
Kostenlos starten →